Fayssal Mostafa Farahat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fayssal Mostafa Farahat has a total of 275 co-authors. Here are the top co-authors by number of shared publications:
- Diane Schertler Rohlman
Center for Research on Occupational and Environmental Toxicology, Oregon Health & Science University, Portland, OR 97239, USA
7 shared publications - Pamela J. Lein
University of California, Davis
7 shared publications - James R. Olson
Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
5 shared publications - Matthew R. Bonner
Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
5 shared publications Abdulhakeem Althaqafi
Infectious Diseases, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Jeddah, SAU
4 shared publications- Caitlyn T. Solem
Pharmerit International, Bethesda, MD, USA
4 shared publications
Latest Publications
- 15 April 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (6) , 604-611
Prophylactic sucrose via the tahneek technique and its effect on neonatal hypoglycemia randomized control trial
Background: The study examined the medical impact of tahneek with dates on hypoglycemia in high-risk newborns. Tahneek, an Islamic tradition, may offer benefits such as stimulating mouth muscles and aiding in breastfeeding initiation. The study assessed its efficacy in comparison with routine feeding practices on blood glucose levels and neonatal intensive care unit (NICU) admissions in high-risk newborns. By addressing neonatal hypoglycemia risks, this research uniquely explored the potential synergy between tradition and contemporary medical strategies. Methods: This single-center, open-label, randomized controlled clinical trial was conducted at King Abdulaziz Medical City, Jeddah, Saudi Arabia, and included neonates at risk of developing hypoglycemia. A total of 324 subjects participated: 162 in the intervention group, 162 in the control. The intervention group received a single dose of soft date paste containing glucose equivalent to 200 mg/kg at 1 h after birth; the control group received routine feeds. Blood glucose levels were monitored by standard protocols. Conclusions: The main outcome measures included the incidence of hypoglycemia and the need for NICU admission for hypoglycemia. The study found no significant difference in hypoglycemia incidence (11.7 vs 14.11, p = .51) or NICU admissions for hypoglycemia (0.12% vs 0.18%, p = .69) between the intervention and control groups, respectively. Exclusive breastfeeding showed a slight preference in the intervention group. Study concluded that tahneek with dates did not reduce the occurrence of hypoglycemia or the need for NICU admissions. However, the practice was deemed safe, culturally accepted, noninvasive, and well tolerated by neonates.
- 15 April 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (6) , 604-611
Prophylactic sucrose via the tahneek technique and its effect on neonatal hypoglycemia randomized control trial
Background: The study examined the medical impact of tahneek with dates on hypoglycemia in high-risk newborns. Tahneek, an Islamic tradition, may offer benefits such as stimulating mouth muscles and aiding in breastfeeding initiation. The study assessed its efficacy in comparison with routine feeding practices on blood glucose levels and neonatal intensive care unit (NICU) admissions in high-risk newborns. By addressing neonatal hypoglycemia risks, this research uniquely explored the potential synergy between tradition and contemporary medical strategies. Methods: This single-center, open-label, randomized controlled clinical trial was conducted at King Abdulaziz Medical City, Jeddah, Saudi Arabia, and included neonates at risk of developing hypoglycemia. A total of 324 subjects participated: 162 in the intervention group, 162 in the control. The intervention group received a single dose of soft date paste containing glucose equivalent to 200 mg/kg at 1 h after birth; the control group received routine feeds. Blood glucose levels were monitored by standard protocols. Conclusions: The main outcome measures included the incidence of hypoglycemia and the need for NICU admission for hypoglycemia. The study found no significant difference in hypoglycemia incidence (11.7 vs 14.11, p = .51) or NICU admissions for hypoglycemia (0.12% vs 0.18%, p = .69) between the intervention and control groups, respectively. Exclusive breastfeeding showed a slight preference in the intervention group. Study concluded that tahneek with dates did not reduce the occurrence of hypoglycemia or the need for NICU admissions. However, the practice was deemed safe, culturally accepted, noninvasive, and well tolerated by neonates.
- Open Access
- 6 August 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1453167
Consensus based recommendations for the management of post-COVID long-term sequelae (Long COVID): a regional perspective
Background and objective: The coronavirus disease 2019 (COVID-19) pandemic marks the biggest public health emergency of the 21st century. The long-term health issues linked to COVID-19, also known as Long COVID, pose a great challenge to patients and society. This article aims to highlight the current unmet clinical needs and present expert recommendations for region-specific assessment and management of Long COVID.Methods: A secondary desk research was performed focusing on global and regional guidelines for the assessment and management of Long COVID. The observations from the desk research form the foundation for the consensus statements. Additionally, an expert panel consisting of 10 consultant physicians from related specialties reviewed these guidelines and literature in advisory board meetings to identify unmet needs, bridge clinical gaps, and develop recommendations for the evaluation and management of Long COVID.Results: The expert recommendation statements were drafted based on overarching principles for the clinical assessment and management of Long COVID. The overarching principles used a targeted, multidisciplinary approach, and collaboration between multiple specialties of healthcare. The panel also highlighted the value of holistic care for the management of Long COVID.Conclusion: Long COVID is a major public health challenge. These expert recommendations are expected to guide healthcare professionals in their clinical decision-making for the assessment, management, and appropriate rehabilitation of patients with Long COVID.
- 6 August 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1453167
Open AccessConsensus based recommendations for the management of post-COVID long-term sequelae (Long COVID): a regional perspective
Background and objective: The coronavirus disease 2019 (COVID-19) pandemic marks the biggest public health emergency of the 21st century. The long-term health issues linked to COVID-19, also known as Long COVID, pose a great challenge to patients and society. This article aims to highlight the current unmet clinical needs and present expert recommendations for region-specific assessment and management of Long COVID.Methods: A secondary desk research was performed focusing on global and regional guidelines for the assessment and management of Long COVID. The observations from the desk research form the foundation for the consensus statements. Additionally, an expert panel consisting of 10 consultant physicians from related specialties reviewed these guidelines and literature in advisory board meetings to identify unmet needs, bridge clinical gaps, and develop recommendations for the evaluation and management of Long COVID.Results: The expert recommendation statements were drafted based on overarching principles for the clinical assessment and management of Long COVID. The overarching principles used a targeted, multidisciplinary approach, and collaboration between multiple specialties of healthcare. The panel also highlighted the value of holistic care for the management of Long COVID.Conclusion: Long COVID is a major public health challenge. These expert recommendations are expected to guide healthcare professionals in their clinical decision-making for the assessment, management, and appropriate rehabilitation of patients with Long COVID.
- Open Access
- 26 November 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (1) , 102600
Narrative review of factors associated with SARS-CoV-2 coinfection in Middle Eastern countries and the need to vaccinate against preventable diseases
- 26 November 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (1) , 102600
Open AccessNarrative review of factors associated with SARS-CoV-2 coinfection in Middle Eastern countries and the need to vaccinate against preventable diseases
- Open Access
- 17 September 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (11) , 102547
Hajj vaccination strategies: Preparedness for risk mitigation
- 17 September 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (11) , 102547
Open AccessHajj vaccination strategies: Preparedness for risk mitigation
- Open Access
- 22 July 2023
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (10) , 1525-1530
Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia
- 22 July 2023
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (10) , 1525-1530
Open AccessBloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia
- Open Access
- 23 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28359
The Incidence of Respiratory Infections and Risk Factors Among Cancer Patients Undergoing Chemotherapy at a Tertiary Care Hospital in Western Saudi Arabia
Cancer patients receiving chemotherapy are prone to infections because of the treatment regimens' immunosuppression. This study estimated the overall incidence of respiratory infections among patients undergoing chemotherapy and associated risk factors. This study is a retrospective chart review of cancer patients at Princess Noorah Oncology Center in Western Saudi Arabia from January 2017 to December 2020. This study included 196 patients, 53.1% males and 50.5% older than 50 years. The estimated incidence of respiratory infections among participants was 8.7%, and the most commonly detected organism was Klebsiella pneumoniae (35.3%). The risk factors significantly associated with infection were ICU admission (p=0.001), the use of mechanical ventilation (p=0.003), and the presence of hematologic malignancy (p=0.02). Future multi-center studies should employ a prospective design, including laboratory confirmation of causative organisms. Such studies may better estimate the infection-associated burden on cancer patients undergoing chemotherapy.
- 23 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28359
Open AccessThe Incidence of Respiratory Infections and Risk Factors Among Cancer Patients Undergoing Chemotherapy at a Tertiary Care Hospital in Western Saudi Arabia
Cancer patients receiving chemotherapy are prone to infections because of the treatment regimens' immunosuppression. This study estimated the overall incidence of respiratory infections among patients undergoing chemotherapy and associated risk factors. This study is a retrospective chart review of cancer patients at Princess Noorah Oncology Center in Western Saudi Arabia from January 2017 to December 2020. This study included 196 patients, 53.1% males and 50.5% older than 50 years. The estimated incidence of respiratory infections among participants was 8.7%, and the most commonly detected organism was Klebsiella pneumoniae (35.3%). The risk factors significantly associated with infection were ICU admission (p=0.001), the use of mechanical ventilation (p=0.003), and the presence of hematologic malignancy (p=0.02). Future multi-center studies should employ a prospective design, including laboratory confirmation of causative organisms. Such studies may better estimate the infection-associated burden on cancer patients undergoing chemotherapy.
- Open Access
- 23 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26266
The Association Between Vitamin D Serum Level and COVID-19 Patients’ Outcomes in a Tertiary Center in Saudi Arabia: A Retrospective Cohort Study
Vitamin D deficiency has been associated with the risk for immune-mediated inflammatory reactions in various respiratory infections. Our study investigated the association between vitamin D deficiency and coronavirus disease 2019 (COVID-19) patients’ outcomes. We included 545 patients who were admitted to a tertiary center in Jeddah, Saudi Arabia from March 2020 to July 2021 with a vitamin D serum test result at the time of infection or prior to disease onset. The data were extracted retrospectively using a data collection sheet. Our primary outcomes were intensive care unit (ICU) admission and in-hospital mortality. The cut-off values for vitamin D were <25, 25-49, and 50-250 for deficient, suboptimal, and optimal levels respectively. Our result revealed that there is no association between vitamin D serum levels deficiency and ICU admission (OR=1.08, p=0.75) or in-hospital mortality (OR=1.74, p=0.97). ICU admission and in-hospital mortality percentages in patients with vitamin D deficiency were 14.1% and 6.4%, respectively. In comparison, percentages for patients with optimal levels were 16.67% and 6.15% for ICU admission and in-hospital mortality, respectively. Smoking was not associated with ICU admission (p=0.05) or in-hospital mortality (p=0.38). Our study does not support a relationship between vitamin D deficiency and COVID-19 patients’ outcomes. Future studies should be directed toward conducting randomized clinical trials to determine whether vitamin D has an effective role in reducing COVID-19 severity.
- 23 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26266
Open AccessThe Association Between Vitamin D Serum Level and COVID-19 Patients’ Outcomes in a Tertiary Center in Saudi Arabia: A Retrospective Cohort Study
Vitamin D deficiency has been associated with the risk for immune-mediated inflammatory reactions in various respiratory infections. Our study investigated the association between vitamin D deficiency and coronavirus disease 2019 (COVID-19) patients’ outcomes. We included 545 patients who were admitted to a tertiary center in Jeddah, Saudi Arabia from March 2020 to July 2021 with a vitamin D serum test result at the time of infection or prior to disease onset. The data were extracted retrospectively using a data collection sheet. Our primary outcomes were intensive care unit (ICU) admission and in-hospital mortality. The cut-off values for vitamin D were <25, 25-49, and 50-250 for deficient, suboptimal, and optimal levels respectively. Our result revealed that there is no association between vitamin D serum levels deficiency and ICU admission (OR=1.08, p=0.75) or in-hospital mortality (OR=1.74, p=0.97). ICU admission and in-hospital mortality percentages in patients with vitamin D deficiency were 14.1% and 6.4%, respectively. In comparison, percentages for patients with optimal levels were 16.67% and 6.15% for ICU admission and in-hospital mortality, respectively. Smoking was not associated with ICU admission (p=0.05) or in-hospital mortality (p=0.38). Our study does not support a relationship between vitamin D deficiency and COVID-19 patients’ outcomes. Future studies should be directed toward conducting randomized clinical trials to determine whether vitamin D has an effective role in reducing COVID-19 severity.
- Open Access
- 19 May 2022
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 11 (4) , 1343-1369
Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review
Invasive meningococcal disease (IMD) outbreaks associated with Hajj and Umrah pilgrimage events in the Kingdom of Saudi Arabia (KSA) are well recognized. Past outbreaks have been associated with substantial intercontinental spread of specific Neisseria meningitidis serogroups. The emergence of meningococcal serogroup W (MenW) was a global concern following the 2000/2001 Hajj outbreaks. Broader compulsory meningococcal serogroups A, C, W and Y (MenACWY) immunization strategies for pilgrims were introduced in response to these events and led to substantial declines in IMD cases associated with these mass gatherings. However, there remains potential for future outbreaks either within KSA during the Hajj or in local populations via pilgrim meningococcal transmission on their return. While the annual Hajj involves pilgrims from over 185 countries, two-thirds of these arrive from 13 countries, chiefly from across South-East Asia, the Middle East and North African (MENA) regions; for which we review the relevant epidemiology of IMD and meningococcal carriage. While disease surveillance is limited and data are often lacking, MenB is an important serogroup associated with IMD and carriage in a number of countries. Available literature suggests that most pilgrims receive polysaccharide MenACWY vaccines (which do not impact carriage and onward transmission) and incomplete compliance with visa/entry immunization regulations is reported. Existing preventative approaches for visiting pilgrims require continued oversight. More complete compliance and switching to the conjugated MenACWY vaccine can provide more robust and broader protection for pilgrims. Additional immunization options could also be considered. Graphical Plain Language Summary
- 19 May 2022
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 11 (4) , 1343-1369
Open AccessMeningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review
Invasive meningococcal disease (IMD) outbreaks associated with Hajj and Umrah pilgrimage events in the Kingdom of Saudi Arabia (KSA) are well recognized. Past outbreaks have been associated with substantial intercontinental spread of specific Neisseria meningitidis serogroups. The emergence of meningococcal serogroup W (MenW) was a global concern following the 2000/2001 Hajj outbreaks. Broader compulsory meningococcal serogroups A, C, W and Y (MenACWY) immunization strategies for pilgrims were introduced in response to these events and led to substantial declines in IMD cases associated with these mass gatherings. However, there remains potential for future outbreaks either within KSA during the Hajj or in local populations via pilgrim meningococcal transmission on their return. While the annual Hajj involves pilgrims from over 185 countries, two-thirds of these arrive from 13 countries, chiefly from across South-East Asia, the Middle East and North African (MENA) regions; for which we review the relevant epidemiology of IMD and meningococcal carriage. While disease surveillance is limited and data are often lacking, MenB is an important serogroup associated with IMD and carriage in a number of countries. Available literature suggests that most pilgrims receive polysaccharide MenACWY vaccines (which do not impact carriage and onward transmission) and incomplete compliance with visa/entry immunization regulations is reported. Existing preventative approaches for visiting pilgrims require continued oversight. More complete compliance and switching to the conjugated MenACWY vaccine can provide more robust and broader protection for pilgrims. Additional immunization options could also be considered. Graphical Plain Language Summary
- Open Access
- 13 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22168
Assessing the Effectiveness of Antibiotic Therapy Against Common Gram-Negative Bacteria in a Saudi Arabian Hospital Using the Drug Resistance Index
Introduction: Assessing the effectiveness of antibiotics and communicating the problem of resistance are essential when devising antimicrobial stewardship programs (ASPs) in hospital settings. The Drug Resistance Index (DRI) is a useful tool that combines antibiotic consumption and bacterial resistance into a single measure. In this study, we used the DRI to assess the impact of introducing a new antibiotic restriction form on antibiotic effectiveness for the treatment of Gram-negative infections in the intensive care unit (ICU). Methods: This was an observational study to assess and evaluate the antibiotic susceptibility of Gram-negative bacteria and antibiotic prescribing rates for the antibiotics indicated for Gram-negative bacteria following the introduction of a new antibiotic restriction form. The study was conducted from 2015 to 2017 at King Abdulaziz Medical City, a tertiary care facility in Jeddah, Saudi Arabia. Changes in antibiotic effectiveness before and after the introduction of the form were evaluated by calculating the DRI for four of the most common Gram-negative pathogens and eight commonly used antibiotic classes. Results: The overall DRI for the adult ICU was higher (59.45) in comparison to the hospital-wide DRI (47.96). A higher DRI was evident for carbapenems and antipseudomonal penicillins + beta-lactamase inhibitors. Acinetobacter baumannii had the highest DRI followed by Klebsiella pneumoniae in both the adult ICU and hospital-wide. After the implementation of antibiotic restriction in the adult ICU, the DRI for carbapenems was significantly lower in the post-intervention phase (from 31.61 to 26.05) (p = 0.031). Conclusion: The DRI is a useful tool for tracking the effectiveness of antibiotics over time. The results of our study are significant in the way that it highlights the importance of having an effective antibiotic stewardship program in healthcare settings and regular feedback of antibiotic consumption data to the stakeholders to keep the antibiotic prescriptions in check, thereby ensuring their sustained effectiveness.
- 13 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22168
Open AccessAssessing the Effectiveness of Antibiotic Therapy Against Common Gram-Negative Bacteria in a Saudi Arabian Hospital Using the Drug Resistance Index
Introduction: Assessing the effectiveness of antibiotics and communicating the problem of resistance are essential when devising antimicrobial stewardship programs (ASPs) in hospital settings. The Drug Resistance Index (DRI) is a useful tool that combines antibiotic consumption and bacterial resistance into a single measure. In this study, we used the DRI to assess the impact of introducing a new antibiotic restriction form on antibiotic effectiveness for the treatment of Gram-negative infections in the intensive care unit (ICU). Methods: This was an observational study to assess and evaluate the antibiotic susceptibility of Gram-negative bacteria and antibiotic prescribing rates for the antibiotics indicated for Gram-negative bacteria following the introduction of a new antibiotic restriction form. The study was conducted from 2015 to 2017 at King Abdulaziz Medical City, a tertiary care facility in Jeddah, Saudi Arabia. Changes in antibiotic effectiveness before and after the introduction of the form were evaluated by calculating the DRI for four of the most common Gram-negative pathogens and eight commonly used antibiotic classes. Results: The overall DRI for the adult ICU was higher (59.45) in comparison to the hospital-wide DRI (47.96). A higher DRI was evident for carbapenems and antipseudomonal penicillins + beta-lactamase inhibitors. Acinetobacter baumannii had the highest DRI followed by Klebsiella pneumoniae in both the adult ICU and hospital-wide. After the implementation of antibiotic restriction in the adult ICU, the DRI for carbapenems was significantly lower in the post-intervention phase (from 31.61 to 26.05) (p = 0.031). Conclusion: The DRI is a useful tool for tracking the effectiveness of antibiotics over time. The results of our study are significant in the way that it highlights the importance of having an effective antibiotic stewardship program in healthcare settings and regular feedback of antibiotic consumption data to the stakeholders to keep the antibiotic prescriptions in check, thereby ensuring their sustained effectiveness.
- Open Access
- 24 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20666
A Retrospective Chart Review of Skin Cancer Pattern and Clinical Outcomes Among Saudi Patients Visiting a Tertiary Care Hospital in Western Saudi Arabia From 1987–2016
Skin cancer is one of the most common cancers worldwide. However, limited studies have been conducted on this disease in Saudi Arabia. This study aimed to describe the prevalence, treatment modalities, and outcomes of skin cancer in a tertiary care hospital in western Saudi Arabia. A retrospective review of the medical records of all Saudi patients visiting King Abdulaziz Medical City hospital in Jeddah between 1987 and 2016 was performed. In total, 132 patients were diagnosed with skin cancer during the study period, however, only 119 cases were analyzed because of missing information. The male-to-female ratio was 1.09:1. The age at diagnosis ranges from 16-94 (mean age: 63.3 years). The most common type of skin cancer was basal cell carcinoma, followed by squamous cell carcinoma and malignant melanoma. The most common anatomical site was the head and neck region. The most common form of treatment modality was surgery. Of the studied patients, 49.6% were cured, 20.2% were in remission, 12.6% relapsed, and 17.6% died. This study showed an equal male to female ratio with variant cumulative incidence over the years. Surgery was the most common treatment modality and had the highest curative outcome. Primary care physicians should be probed further to raise awareness and screen their patients to ensure early detection of possible skin cancer.
- 24 December 2021
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20666
Open AccessA Retrospective Chart Review of Skin Cancer Pattern and Clinical Outcomes Among Saudi Patients Visiting a Tertiary Care Hospital in Western Saudi Arabia From 1987–2016
Skin cancer is one of the most common cancers worldwide. However, limited studies have been conducted on this disease in Saudi Arabia. This study aimed to describe the prevalence, treatment modalities, and outcomes of skin cancer in a tertiary care hospital in western Saudi Arabia. A retrospective review of the medical records of all Saudi patients visiting King Abdulaziz Medical City hospital in Jeddah between 1987 and 2016 was performed. In total, 132 patients were diagnosed with skin cancer during the study period, however, only 119 cases were analyzed because of missing information. The male-to-female ratio was 1.09:1. The age at diagnosis ranges from 16-94 (mean age: 63.3 years). The most common type of skin cancer was basal cell carcinoma, followed by squamous cell carcinoma and malignant melanoma. The most common anatomical site was the head and neck region. The most common form of treatment modality was surgery. Of the studied patients, 49.6% were cured, 20.2% were in remission, 12.6% relapsed, and 17.6% died. This study showed an equal male to female ratio with variant cumulative incidence over the years. Surgery was the most common treatment modality and had the highest curative outcome. Primary care physicians should be probed further to raise awareness and screen their patients to ensure early detection of possible skin cancer.